neamine has been researched along with Angiogenesis, Pathologic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, GF; Ibaragi, S; Kishimoto, K; Sasaki, A; Yoshida, S; Yoshioka, N | 1 |
An, S; Hu, G; Liu, Y; Wu, Y; Zhang, X | 1 |
Hirukawa, S; Hu, GF; Olson, KA; Tsuji, T | 1 |
3 other study(ies) available for neamine and Angiogenesis, Pathologic
Article | Year |
---|---|
Neamine inhibits oral cancer progression by suppressing angiogenin-mediated angiogenesis and cancer cell proliferation.
Topics: Angiogenesis Inducing Agents; Animals; Cell Line, Tumor; Cell Proliferation; Disease Progression; Framycetin; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Mice, Nude; Mouth Neoplasms; Neovascularization, Pathologic; Protein Transport; Ribonuclease, Pancreatic; Xenograft Model Antitumor Assays | 2014 |
Pharmacokinetics of neamine in rats and anti-cervical cancer activity in vitro and in vivo.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Area Under Curve; Biological Availability; Cell Proliferation; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Framycetin; Half-Life; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Ribonuclease, Pancreatic; Tissue Array Analysis; Up-Regulation; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2015 |
Neamine inhibits xenografic human tumor growth and angiogenesis in athymic mice.
Topics: Active Transport, Cell Nucleus; Aminoglycosides; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Nucleus; Cell Proliferation; Endothelial Cells; Framycetin; Humans; Mice; Mice, Nude; Neoplasms; Neovascularization, Pathologic; Ribonuclease, Pancreatic; Umbilical Veins; Xenograft Model Antitumor Assays | 2005 |